Skip to main content

Table 2 Laboratory tests

From: Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

 

ISR group

N-ISR group

t/χ2

P

WBC,10^9/L

6.69 ± 1.91

6.76 ± 1.92

−0.198

0.843

N, 10^9/L

4.34 ± 1.68

5.13 ± 7.26

−1.126

0.262

RBC, 10^12/L

4.50 ± 0.62

4.58 ± 0.50

−0.779

0.493

Hb, g/L

134.88 ± 15.85

140.09 ± 15.66

−1.843

0.067

Plt, 10^9/L

223.41 ± 67.44

209.94 ± 60.24

1.139

0.259

ALT, U/L

30.51 ± 29.70

32.96 ± 36.87

−0.431

0.668

AST, U/L

26.71 ± 17.65

28.98 ± 29.51

−0.595

0.553

ALP, U/L

83.75 ± 38.41

81.66 ± 24.72

0.327

0.745

TBIL, μmol/L

12.91 ± 5.95

12.31 ± 4.97

0.584

0.562

DBIL, μmol/L

4.06 ± 3.26

3.98 ± 1.92

0.148

0.883

Cholesterol, mmol/L

3.94 ± 1.13

3.96 ± 1.51

−0.095

0.924

TG, mmol/L

1.55 ± 0.86

1.95 ± 1.81

−1.889

0.061

HDL-C, mmol/L

1.09 ± 0.30

1.06 ± 0.23

0.644

0.522

LDL-C, mmol/L

2.10 ± 0.85

2.01 ± 0.81

0.550

0.584

Cr, mmol/L

71.95 ± 22.85

76.31 ± 22.43

−1.067

0.290

Glu > 6.1, mmol/L

34 (82.9%)

49 (39.2%)

23.612

< 0.001

  1. Data are presented as mean ± standard deviation or n (%)
  2. WBC White blood cell, N Neutrophils, RBC Red blood cell, Hb Hemoglobin, Plt Platelet, ALT Alanine aminotransferase, AST Aspartate aminotransaminase, ALP Alkaline phosphatase, TBIL Total bilirubin, DBIL Direct Bilirubin, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Cr Creatinine, Glu Glucose